Pulmonary Benefits of GLP-1 Analogs Versus SGLT-2 Inhibitors in COPD Patients With Coexisting Type 2 Diabetes
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
American Journal of Respiratory and Critical Care Medicine
Conference Name
American Thoracic Society (ATS) International Conference
Conference Date
2025-05-16 - 2025-05-21
First Page
A2855
DOI
10.1164/ajrccm.2025.211.Abstracts.A2855
Volume
211
Publication Date
5-1-2025
Recommended Citation
Peng, C., See, X., Chiang, C. H., Chang, Y., Nathani, Z., De Luna, D., Xanthavanij, N., Ahmed, O., Wang, T. H., Lee, Y. C., & Chang, K. Y. (2025). Pulmonary Benefits of GLP-1 Analogs Versus SGLT-2 Inhibitors in COPD Patients With Coexisting Type 2 Diabetes. American Journal of Respiratory and Critical Care Medicine, 211, A2855. https://doi.org/10.1164/ajrccm.2025.211.Abstracts.A2855
COinS